Case report: Persistent hypogammaglobulinemia following hematopoietic stem cell transplantation from a sibling donor with heterozygous RAG1 mutation
Frontiers in Immunology · 22.04.2026 · 17
DOI: 10.3389/fimmu.2026.1798445 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Immunology, online erschienen am 22.04.2026. Verfasst von Jing Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Hematology Department, Quanzhou Maternal and Child Health Hospital (Quanzhou Children's Hospital), Quanzhou, China. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Agammaglobulinemia, Homeodomain Proteins, Mutation. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Hematopoietic stem cell transplantation (HSCT) is a curative treatment for pediatric hematologic and immunologic disorders, with successful immune reconstitution being critical for long-term survival. We report the unique case of persistent hypogammaglobulinemia following fully matched HSCT from a phenotypically normal sibling donor carrying a heterozygous RAG1 gene mutation.
Methods
A 13-year-old girl with EBV-associated NK/T-cell lymphoproliferative disorder underwent fully matched sibling HSCT from her mutation-carrying donor. Whole-exome sequencing confirmed the RAG1 c.994C>T (p.Arg332*) mutation in both donor and recipient. Post-transplant monitoring included serial lymphocyte subset measurements and immunoglobulin level monitoring over a 5-year period.
Results
Despite successful engraftment and quantitative T- and B-cell recovery, the patient developed persistent hypogammaglobulinemia. Serum IgG levels declined to below 4g/L at 4 months post-HSCT and remained persistently below 2g/L from 11 months onwards (with only one measurement of 2.57g/L during this period). IgA levels remained consistently below 0.2g/L, becoming undetectable by 11 months and remaining so. IgM levels dropped below the detection threshold at 2 months and demonstrated only partial recovery by 18 months (peak: 0.29g/L). The patient experienced recurrent respiratory infections, necessitating long-term immunoglobulin replacement therapy.
Conclusions
This case demonstrates that heterozygous variants in genes critical for hematopoietic reconstitution (such as RAG1 mutations) may still lead to significant immunodeficiency post-transplantation. Our findings strongly suggest that potential donors carrying such mutations require careful evaluation, with non-carrier donors being preferentially selected when available, especially in the context of HSCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Hematology Department, Quanzhou Maternal and Child Health Hospital (Quanzhou Children's Hospital), Quanzhou, China.
Zitieren
APA
Wu, J., Wang, H., Chen, W., & Hong, Z. (2026). Case report: Persistent hypogammaglobulinemia following hematopoietic stem cell transplantation from a sibling donor with heterozygous RAG1 mutation. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1798445
Vancouver
Wu J, Wang H, Chen W, Hong Z. Case report: Persistent hypogammaglobulinemia following hematopoietic stem cell transplantation from a sibling donor with heterozygous RAG1 mutation. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1798445
BibTeX
@article{Wu2026,
author = {Wu, Jing and Wang, Huifang and Chen, Weijie and Hong, Zhiming},
title = {Case report: Persistent hypogammaglobulinemia following hematopoietic stem cell transplantation from a sibling donor with heterozygous RAG1 mutation},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1798445}
}
EUVIMED